Intel Corporation (NASDAQ:INTC) experienced a staggering $52.9 billion decline in market capitalization between July 2 and July 10, 2026, a drop that far surpasses the implied value of its stake in Altera. Shares closed at $109.84 on Friday, down 2.4% for the day and 8.7% over the period, highlighting broader concerns about the chipmaker's core business.
The sell-off comes as Intel prepares for the initial public offering of Altera, its field-programmable gate array (FPGA) unit. Altera CEO Raghib Hussain stated on Friday that the company's revenue grew over 20% last year and is expected to rise in the mid-20% range this year. Operating income is projected to more than double as Altera moves toward a public listing. Intel retains a 49% stake after selling 51% to Silver Lake for $4.46 billion, valuing Altera at $8.75 billion.
Based on this valuation, Intel's stake is worth approximately $4.29 billion, or $0.85 per Intel share, representing less than 0.8% of Intel's current market cap. Even if Altera's valuation doubles to $17.5 billion at listing, Intel would gain an additional $4.29 billion, still less than a third of the value lost in a single trading session. The disparity underscores that Altera's contribution, while positive, cannot compensate for weaknesses in Intel's processor and foundry operations.
Intel's decline outpaced the broader semiconductor sector. Over the five-day period, Intel lagged Advanced Micro Devices (NASDAQ:AMD) by 11.2 percentage points and the PHLX Semiconductor Index by 12.8 points. Despite this, Intel remains up 197.67% year-to-date, reflecting earlier gains. In contrast, AMD rose 2.04% on Friday and is up 160.50% for the year.
Analyst commentary suggests limited near-term upside. Stifel Financial (NYSE:SF) analyst Ruben Roy raised his price target on Intel to $120 from $75 on Friday but maintained a Hold rating. The new target implies a 9.2% upside from Friday's close. Roy noted that AI-focused infrastructure firms remain constrained more by supply than demand, with order backlogs supporting growth. However, the Hold rating indicates no immediate buy recommendation, reflecting caution on Intel's valuation.
The broader market showed resilience despite Intel's weakness. The S&P 500 rose 0.42% on Friday, the Nasdaq gained 0.29%, and the PHLX Semiconductor Index edged up 0.06%. Analysts expect approximately 24% earnings growth for S&P 500 companies in the second quarter. Terry Sandven, chief equity strategist at U.S. Bank Wealth Management, described it as a "high-bar quarter with a narrow margin of error."
Investors are now focused on upcoming earnings reports from key industry players. ASML Holding (NASDAQ:ASML) reports on Wednesday, followed by Taiwan Semiconductor Manufacturing Co. (NYSE:TSM) on Thursday, ahead of Intel's own second-quarter results on July 23. Economic data, including June consumer and producer price indices and retail sales, will also influence market sentiment. Michael Reynolds, vice president of investment strategy at Glenmede, noted, "A lot of factors coming to a head all at once."
For Intel, the Altera IPO represents a potential source of cash, but the math suggests it will not be a game-changer. If the listing achieves a higher valuation or Intel sells additional shares, the proceeds could increase, but taxes, transaction costs, and discounts on a non-controlling stake could reduce Intel's net take. The more significant risks lie in Intel's core business: weakening server processor demand, lagging foundry yields, or disappointing margins on July 23 could easily overshadow any benefit from Altera.
As Intel's market cap hovers near $552 billion, the central question for investors is whether the company can translate its processor and manufacturing strengths into sustainable profitability. Altera provides a modest boost, but at the current deal price, it is insufficient to move the stock significantly.
